Duan; Jian-Xin
Patent Applications and Registrations
Patent applications and USPTO patent grants for Duan; Jian-Xin.The latest application filed is for "nitrobenzyl derivatives of anti-cancer agents".
Company Profile
9.21.29
- Duan; Jian-Xin - South San Francisco CA
- Duan; Jian-Xin - Austin TX
- Duan; Jian-Xin - Redwood City CA US
- Duan; Jian-Xin - So. San Francisco CA US
- Duan; Jian-Xin - San Francisco CA
- Duan, Jian-Xin - Gainesville FL
Patent Activity
| Patent | Date |
|---|---|
| Nitrobenzyl Derivatives Of Anti-cancer Agents App 20210017120 - Duan; Jian-Xin ; et al. | 2021-01-21 |
| Nitrobenzyl derivatives of anti-cancer agents Grant 10,829,437 - Duan , et al. November 10, 2 | 2020-11-10 |
| DNA alkylating agents Grant 10,766,914 - Duan , et al. Sep | 2020-09-08 |
| Aziridine containing DNA alkylating agents Grant 10,668,047 - Matteucci , et al. | 2020-06-02 |
| TH-302 solid forms and methods related thereto Grant 10,654,876 - Duan , et al. | 2020-05-19 |
| Aziridine Containing Dna Alkylating Agents App 20200085786 - Matteucci; Mark ; et al. | 2020-03-19 |
| (R)- and (S)-1-(3-(3-N,N-dimethylaminocarbonyl)phenoxyl-4-nitrophenyl)-1-e- thyl-N,N'-bis (ethylene)phosphoramidate, compositions and methods for their use and preparation Grant 10,409,869 - Duan , et al. Sept | 2019-09-10 |
| DNA alkylating agents Grant 10,364,261 - Duan , et al. | 2019-07-30 |
| Dna Alkylating Agents App 20190225633 - Duan; Jian-Xin ; et al. | 2019-07-25 |
| Th-302 Solid Forms And Methods Related Thereto App 20190127404 - Duan; Jian-Xin ; et al. | 2019-05-02 |
| TH-302 solid forms and methods related thereto Grant 10,131,683 - Duan , et al. November 20, 2 | 2018-11-20 |
| (r)- And (s)-1-(3-(3-n,n-dimethylaminocarbonyl)phenoxyl-4-nitrophenyl)-1-e- Thyl-n,n'-bis (ethylene)phosphoramidate, Compositions And Methods For Their Use And Preparation App 20180258116 - Duan; Jian-Xin ; et al. | 2018-09-13 |
| Aziridine Containing Dna Alkylating Agents App 20180169064 - Matteucci; Mark ; et al. | 2018-06-21 |
| Nitrobenzyl Derivatives Of Anti-cancer Agents App 20180086693 - Duan; Jian-Xin ; et al. | 2018-03-29 |
| Dna Alkylating Agents App 20180044360 - Duan; Jian-Xin ; et al. | 2018-02-15 |
| Th-302 Solid Forms And Methods Related Thereto App 20170210769 - Duan; Jian-Xin ; et al. | 2017-07-27 |
| Phosphoramidate alkylator prodrugs Grant 9,226,932 - Matteucci , et al. January 5, 2 | 2016-01-05 |
| Treatment of Cancer with Glufosfamide in Patients Not Receiving Insulin Therapy App 20150272973 - Handisides; Damian ; et al. | 2015-10-01 |
| Treatment Of Cancer Using Hypoxia Activated Prodrugs App 20150258125 - Curd; John G. ; et al. | 2015-09-17 |
| Treatment of cancer using hypoxia activated prodrugs Grant 8,946,275 - Curd , et al. February 3, 2 | 2015-02-03 |
| Treatment of cancer with glufosfamide in patients not receiving insulin therapy Grant 8,765,690 - Handisides , et al. July 1, 2 | 2014-07-01 |
| Phosphoramidate Alkylator Prodrugs App 20140170240 - Matteucci; Mark ; et al. | 2014-06-19 |
| Phosphoramidate alkylator prodrugs Grant 8,664,204 - Matteucci , et al. March 4, 2 | 2014-03-04 |
| Phosphoramidate Alkylator Prodrugs App 20130303778 - Matteucci; Mark ; et al. | 2013-11-14 |
| Camptothecin derivatives Grant 8,575,188 - Cai , et al. November 5, 2 | 2013-11-05 |
| Phosphoramidate alkylator prodrugs for the treatment of cancer Grant 8,552,048 - Ammons , et al. October 8, 2 | 2013-10-08 |
| Phosphoramidate alkylator prodrugs Grant 8,507,464 - Matteucci , et al. August 13, 2 | 2013-08-13 |
| Treatment of Cancer Using Hypoxia Activated Prodrugs App 20130202716 - Curd; John G. ; et al. | 2013-08-08 |
| Camptothecin Derivatives App 20120165522 - Cai; Xiaohong ; et al. | 2012-06-28 |
| Phosphoramidate Alkylator Prodrugs App 20110251159 - Matteucci; Mark ; et al. | 2011-10-13 |
| Phosphoramidate alkylator prodrugs Grant 8,003,625 - Matteucci , et al. August 23, 2 | 2011-08-23 |
| Phosphoramidate Alkylator Prodrugs For The Treatment Of Cancer App 20100183742 - Ammons; Steve ; et al. | 2010-07-22 |
| Phosphoramidate Alkylator Prodrugs App 20100137254 - Matteucci; Mark ; et al. | 2010-06-03 |
| Glufosfamide Combination Therapy App 20100104549 - Handisides; Damian ; et al. | 2010-04-29 |
| Compositions and Methods for Treating Cancer App 20090312276 - Matteucci; Mark ; et al. | 2009-12-17 |
| Compositions and methods for treating cancer Grant 7,550,496 - Matteucci , et al. June 23, 2 | 2009-06-23 |
| Tubulin Binding Anti Cancer Agents And Prodrugs Thereof App 20090042820 - Matteucci; Mark ; et al. | 2009-02-12 |
| Topoisomerase Inhibitors and Prodrugs App 20080214576 - Matteucci; Mark ; et al. | 2008-09-04 |
| Hypoxia-Activated Anti-Cancer Agents App 20080132458 - Matteucci; Mark ; et al. | 2008-06-05 |
| Anthracycline analogs App 20070060534 - Matteucci; Mark ; et al. | 2007-03-15 |
| Lonidamine analogs App 20070043057 - Matteucci; Mark ; et al. | 2007-02-22 |
| Lonidamine analogs App 20070015771 - Matteucci; Mark ; et al. | 2007-01-18 |
| Compositions and methods for treating cancer App 20060258656 - Matteucci; Mark ; et al. | 2006-11-16 |
| Process for the preparation of derivatives of octafluoro-[2,2]paracylophan- e App 20020026086 - Dolbier, William R. JR. ; et al. | 2002-02-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 